Bank of America’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $126K | Sell |
21,833
-152
| -0.7% | -$965 | ﹤0.01% | 5485 |
|
|
2025
Q4 | $152K | Buy |
21,985
+208
| +1% | +$1.39K | ﹤0.01% | 5464 |
|
|
2025
Q3 | $141K | Sell |
21,777
-3,503
| -14% | -$24.7K | ﹤0.01% | 6440 |
|
|
2025
Q2 | $186K | Buy |
25,280
+7
| +0% | +$49 | ﹤0.01% | 6210 |
|
|
2025
Q1 | $219K | Buy |
25,273
+1
| +0% | +$10 | ﹤0.01% | 6125 |
|
|
2024
Q4 | $217K | Sell |
25,272
-36
| -0.1% | -$181 | ﹤0.01% | 6084 |
|
|
2024
Q3 | $123K | Buy |
25,308
+35
| +0.1% | +$164 | ﹤0.01% | 6236 |
|
|
2024
Q2 | $131K | Sell |
25,273
-553
| -2% | -$2.69K | ﹤0.01% | 6120 |
|
|
2024
Q1 | $127K | Sell |
25,826
-4
| -0% | -$23 | ﹤0.01% | 6127 |
|
|
2023
Q4 | $145K | Hold |
25,830
| – | – | ﹤0.01% | 6229 |
|
|
2023
Q3 | $160K | Hold |
25,830
| – | – | ﹤0.01% | 6018 |
|
|
2023
Q2 | $165K | Hold |
25,830
| – | – | ﹤0.01% | 5965 |
|
|
2023
Q1 | $104K | Buy |
+25,830
| New | +$110K | ﹤0.01% | 6243 |
|
|
2022
Q1 | – | Sell |
-147
| Closed | -$1K | – | 8332 |
|
|
2021
Q4 | $1K | Buy |
+147
| New | +$1.35K | ﹤0.01% | 8042 |
|
|
2021
Q3 | – | Sell |
-1,430
| Closed | -$15K | – | 8142 |
|
|
2021
Q2 | $15K | Sell |
1,430
-4,299
| -75% | -$43.6K | ﹤0.01% | 7213 |
|
|
2021
Q1 | $64K | Buy |
5,729
+2,479
| +76% | +$28.8K | ﹤0.01% | 6550 |
|
|
2020
Q4 | $35K | Buy |
3,250
+1,352
| +71% | +$13.9K | ﹤0.01% | 6446 |
|
|
2020
Q3 | $18K | Sell |
1,898
-4,242
| -69% | -$37.8K | ﹤0.01% | 6312 |
|
|
2020
Q2 | $59K | Buy |
+6,140
| New | +$52.3K | ﹤0.01% | 5900 |
|
|
2019
Q3 | – | Sell |
-129
| Closed | -$1K | – | 7282 |
|
|
2019
Q2 | $1K | Buy |
+129
| New | +$1.13K | ﹤0.01% | 7017 |
|
|
2017
Q4 | – | Sell |
-277
| Closed | -$1K | – | 7052 |
|
|
2017
Q3 | $1K | Buy |
+277
| New | +$848 | ﹤0.01% | 6917 |
|
|
2017
Q2 | – | Sell |
-2,144
| Closed | -$7K | – | 6961 |
|
|
2017
Q1 | $7K | Sell |
2,144
-18
| -0.8% | -$63 | ﹤0.01% | 6610 |
|
|
2016
Q4 | $5K | Sell |
2,162
-4,968
| -70% | -$9.67K | ﹤0.01% | 6693 |
|
|
2016
Q3 | $12K | Buy |
7,130
+5,041
| +241% | +$9.38K | ﹤0.01% | 6318 |
|
|
2016
Q2 | $4K | Hold |
2,089
| – | – | ﹤0.01% | 6722 |
|
|
2016
Q1 | $8K | Sell |
2,089
-1
| -0% | -$4 | ﹤0.01% | 6443 |
|
|
2015
Q4 | $7K | Buy |
2,090
+1
| +0% | +$4 | ﹤0.01% | 6780 |
|
|
2015
Q3 | $11K | Buy |
+2,089
| New | +$13.6K | ﹤0.01% | 6524 |
|
Other funds holding CSBR
BMC
NMC
TAM
VCM
MBAM
Bank of America's CSBR Position: Q1 2026 in Review
Bank of America reduced its Champions Oncology (CSBR) stake by 0.69% in Q1 2026, selling an estimated $965 and leaving 21,833 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #5485.
Bank of America first reported a position in CSBR in Q3 2015 and has held it in 28 quarters since. The position peaked at $219K in Q1 2025. 25 funds tracked by Wall St. Rank hold CSBR as of Q1 2026.
- Bank of America held 21,833 shares of Champions Oncology worth $126K as of Q1 2026.
- Bank of America sold 152 Champions Oncology shares in Q1 2026, an estimated $965.
- Champions Oncology made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5485 holding.
- Bank of America first reported a position in Champions Oncology in Q3 2015 and has held it in 28 quarters since.
- Bank of America's Champions Oncology position peaked at $219K in Q1 2025.
- 25 funds tracked by Wall St. Rank held Champions Oncology as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.